PEPSTAR
LIVE

Serial Number

76434604

Owner

Jerini AG

Attorney

Monica Riva Talley

Filing Date

Jul 25, 2002

Add to watchlist:

No watchlists yet
View on USPTO

PEPSTAR Trademark

Serial Number: 76434604 • Registration: 2868416

PEPSTAR is a trademark filed by Jerini AG on July 25, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Jerini AG (9 trademarks)

Friedrichstrasse 149
10117 Berlin , DE

Entity Type: 03

JPT Peptide Technologies GmbH (9 trademarks)

Volmerstraße 5

Entity Type: 16

Trademark Details

Filing Date

July 25, 2002

Registration Date

August 3, 2004

Published for Opposition

May 11, 2004

Goods & Services

[ Human and veterinary pharmaceutical preparations for the treatment of illnesses caused by defects in signal transduction cascades, namely, cancer, neurodegenerative diseases, allergic diseases and cardiovascular diseases, comprised of amino acids, nucleic acids, peptides, proteins, and peptidomimetics; carrier materials comprised of [ nucleic acids, peptides and proteins for diagnostic purposes for medical treatments ]

[ Chemicals for use in the manufacture of pharmaceuticals; ] carrier materials comprised of [ nucleic acids, ] peptides and proteins for research purposes, for pharmaceutical research, for diagnostic purposes for scientific research, for biochemical research purposes in the field of antibody epitope mapping, proteine/proteine interaction, and enzyme profiling

[ Human and veterinary medical services; pharmaceutical advice; physician services; veterinary services ]

[ Scientific research, namely, immobilization of arrays of chemical compounds, modification of peptides and proteins, transformation of chemical compounds; scientific and technological services and research as well as designer services for third parties in the field of biotechnology and pharmaceuticals, namely, development of new technology for others; design and development of new technology for others in the field of biotechnology and pharmaceuticals; industrial analysis and research services in the field of biotechnology and pharmaceuticals, namely, synthesis and immobilization of chemicals used in industry and science, screening for interaction partners, antibody epitope mapping, proteine/proteine interaction, and enzyme profiling; design and development of computer hardware and software; scientific research in the field of synthesis and immobilization of chemicals use in industry and science; chemical research, namely, screening for chemical interactions of enzymes, enzyme substrates, antigens and antibodies; development of inhibitors of receptors and enzymes, namely, kinases, oxydoreductases, transerases, hydrolases, lyases, isomerases, and ligases; research and development of diagnostic assays, assays for pharmaceutical drug discovery and assays for target validation, namely, methods for antigene detection and enzyme substrate identification for others; product research and development of chemicals used in industry and science; computer programming for other for the herein aforementioned purposes; agricultural research; scientific research; industrial design; computer programming for others; chemist, biologist, biochemist, biotechnologist, gene technologist, molecular biologist, pharmacology, and physicist services ]

[ Custom synthesis of chemicals used in industry and science for third parties; custom immobilization of arrays of chemicals compounds for others, custom modification of peptides and proteins for others and custom transformation of chemical compounds for others]

[ Analytical device, namely, nanoplotter for medical purposes, comprised primarily of computer programs for synthesis and immobilization of chemicals, for the analysis of patterns on surfaces, and for the screening of chemical compounds ]

[ Scientific measuring and checking apparatus and instruments, namely, micro-array scanner comprised of filters and cellulose or polypropylene membranes for use in the field of biotechnology, pharmacology and for use in pharmaceutical research; analytical device, namely, robot, synthesizer, spotter and nanoplotter for non-medical purposes, comprised primarily of computer programs for synthesis and immobilization of chemicals, for the analysis of patterns on surfaces, and for the screening of chemical compounds ]

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 22, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 22, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 22, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 22, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 22, 2025 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sep 12, 2024 NA89
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Sep 12, 2024 RNL2
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 12, 2024 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 10, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Jun 26, 2024 E89R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 27, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 27, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 27, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 27, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 27, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 27, 2023 COAR
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Aug 3, 2023 REM2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 7, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 7, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 7, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 7, 2022 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 22, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 22, 2019 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 31, 2018 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 17, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 17, 2015 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Aug 19, 2014 NAS8
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Aug 19, 2014 RNL1
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
Aug 19, 2014 9G8P
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
Aug 19, 2014 8PRT
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 19, 2014 APRE
TEAS SECTION 8 & 9 RECEIVED
Jul 31, 2014 E89R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 22, 2011 TCCA
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 9, 2010 C15P
AMENDMENT UNDER SECTION 7 - PROCESSED
Aug 9, 2010 A7OK
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Aug 6, 2010 815F
SEC 7 REQUEST FILED
Aug 6, 2010 AMD7
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Aug 6, 2010 EROP
POST REGISTRATION ACTION MAILED - SEC. 7
Aug 4, 2010 PRAM
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 3, 2010 APRE
TEAS SECTION 7 REQUEST RECEIVED
Aug 2, 2010 ES7R
TEAS SECTION 8 & 15 RECEIVED
Jul 30, 2010 E815
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 12, 2010 ASGN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 9, 2010 TCCA
REVIEW OF CORRESPONDENCE COMPLETE
Oct 24, 2007 CORV
PAPER RECEIVED
Oct 18, 2007 MAIL
EXPARTE APPEAL TERMINATED
Aug 4, 2004 EXPT
REGISTERED-PRINCIPAL REGISTER
Aug 3, 2004 R.PR
PAPER RECEIVED
Jun 18, 2004 MAIL
PUBLISHED FOR OPPOSITION
May 11, 2004 PUBO
NOTICE OF PUBLICATION
Apr 21, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 20, 2004 CNSA
CASE FILE IN TICRS
Jan 28, 2004 CFIT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 23, 2004 JURT
EX PARTE APPEAL-INSTITUTED
Jan 23, 2004 EXPI
EXPARTE APPEAL RECEIVED AT TTAB
Jan 9, 2004 EXAF
FINAL REFUSAL MAILED
Jul 9, 2003 CNFR
Sec. 1(B) CLAIM DELETED
May 6, 2003 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2003 CRFA
PAPER RECEIVED
May 6, 2003 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 20, 2003 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2003 CRFA
ASSIGNED TO EXAMINER
Jan 3, 2003 DOCK
NON-FINAL ACTION MAILED
Nov 8, 2002 CNRT
PAPER RECEIVED
Nov 7, 2002 MAIL
ASSIGNED TO EXAMINER
Nov 5, 2002 DOCK